Nephros Inc (NEPH) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Nephros Inc (NEPH) has a cash flow conversion efficiency ratio of -0.156x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-1.67 Million) by net assets ($10.70 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see NEPH market cap for the company's overall valuation and market capitalisation.
Nephros Inc - Cash Flow Conversion Efficiency Trend (2002–2025)
This chart illustrates how Nephros Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Nephros Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Nephros Inc ranked by their cash flow conversion efficiency. Explore Nephros Inc cash flow quality index to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Aspocomp Group Oyj
HE:ACG1V
|
0.034x |
|
Touax SCA
PA:TOUP
|
0.021x |
|
MACH7 Technologies Ltd
AU:M7T
|
0.073x |
|
Lite Strategy, Inc.
NASDAQ:LITS
|
-0.040x |
|
Perdana Bangun Pusaka Tbk PT
JK:KONI
|
0.056x |
|
Pixelworks Inc
NASDAQ:PXLW
|
-0.106x |
|
Simonds Group Ltd
AU:SIO
|
0.605x |
|
Suzhou QingYue Optoelectronics Technology Co. Ltd. A
SHG:688496
|
N/A |
Annual Cash Flow Conversion Efficiency for Nephros Inc (2002–2025)
The table below shows the annual cash flow conversion efficiency of Nephros Inc from 2002 to 2025. View Nephros Inc stock quote for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $10.20 Million | $1.65 Million | 0.161x | +381.36% |
| 2024-12-31 | $8.59 Million | $-492.00K | -0.057x | -157.92% |
| 2023-12-31 | $8.36 Million | $827.00K | 0.099x | +127.17% |
| 2022-12-31 | $8.88 Million | $-3.23 Million | -0.364x | -279.03% |
| 2021-12-31 | $14.75 Million | $-1.42 Million | -0.096x | +78.33% |
| 2020-12-31 | $15.57 Million | $-6.90 Million | -0.443x | -49.75% |
| 2019-12-31 | $7.69 Million | $-2.28 Million | -0.296x | +45.05% |
| 2018-12-31 | $6.80 Million | $-3.66 Million | -0.539x | -1264.21% |
| 2017-12-31 | $1.95 Million | $-77.00K | -0.039x | +98.75% |
| 2016-12-31 | $667.00K | $-2.11 Million | -3.166x | -121.11% |
| 2015-12-31 | $2.66 Million | $-3.81 Million | -1.432x | -426.07% |
| 2014-12-31 | $-5.68 Million | $-2.50 Million | 0.439x | -92.52% |
| 2013-12-31 | $-610.00K | $-3.58 Million | 5.874x | +125.91% |
| 2012-12-31 | $-595.00K | $-1.55 Million | 2.600x | +385.08% |
| 2011-12-31 | $1.42 Million | $-1.30 Million | -0.912x | +90.47% |
| 2010-12-31 | $135.00K | $-1.29 Million | -9.570x | -617.41% |
| 2009-12-31 | $1.96 Million | $-2.61 Million | -1.334x | +40.95% |
| 2008-12-31 | $2.53 Million | $-5.72 Million | -2.259x | -166.10% |
| 2007-12-31 | $8.76 Million | $-7.43 Million | -0.849x | -124.38% |
| 2006-12-31 | $-2.10 Million | $-7.30 Million | 3.482x | +470.79% |
| 2005-12-31 | $5.38 Million | $-5.05 Million | -0.939x | -15.62% |
| 2004-12-31 | $9.65 Million | $-7.84 Million | -0.812x | -228.14% |
| 2003-12-31 | $-5.38 Million | $-3.41 Million | 0.634x | +180.58% |
| 2002-12-31 | $-8.00 Million | $-1.81 Million | 0.226x | -- |
About Nephros Inc
Nephros, Inc., a commercial-stage company, develops and sells water filtration solutions for medical and commercial applications in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella a… Read more